Evidence map›Paper›PMID 39810252›Full record

Trial reportCancer imaging : the official publication of the International Cancer Imaging Society2025

Jisce R Puik, Thomas T Poels, Gerrit K J Hooijer, Matthijs C F Cysouw, Joanne Verheij, Johanna W Wilmink, Elisa Giovannetti, Geert Kazemier, Arantza Farina Sarasqueta, Daniela E Oprea-Lager and 1 more

Abstract readClinical Trial, Phase IIClinical Trial, Phase I
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Cancer imaging : the official publication of the International Cancer Imaging Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Incidental detection of PDAC viaFrontiers in nuclear medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jisce R Puik *Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, the Netherlands.
Thomas T Poels *Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, the Netherlands.
Gerrit K J HooijerCancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Matthijs C F CysouwCancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Joanne VerheijCancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Johanna W WilminkCancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Elisa GiovannettiCancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Geert KazemierDepartment of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, the Netherlands.
Arantza Farina SarasquetaCancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Daniela E Oprea-LagerCancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Rutger-Jan SwijnenburgDepartment of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, the Netherlands. r.j.swijnenburg@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-3980-4634

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurrent diagnostic imaging modalities have limited ability to differentiate between malignant and benign pancreaticobiliary disease, and lack accuracy in detecting lymph node metastases.

methodsSeventeen patients with clinically resectable PDAC underwent

resultsOut of 17 PSMA PET/CT scans, 13 scans demonstrated positive PSMA tracer uptake, with a mean SUV

conclusions

trial registrationThe trial is registered as PANSCAN-2 in the European Clinical Trials Database (EudraCT number: 2020-002185-14).

Indexed as

Carcinoma, Pancreatic DuctalGlutamate Carboxypeptidase IIPancreatic NeoplasmsPositron Emission Tomography Computed TomographyAgedAged, 80 and overAntigens, SurfaceFemaleFluorine RadioisotopesHumansLymphatic MetastasisMaleMiddle AgedRadiopharmaceuticalsAntigens, SurfaceFluorine RadioisotopesFOLH1 protein, humanGlutamate Carboxypeptidase IIRadiopharmaceuticalsDiagnosisPancreatic cancerPDACPET/CTPSMA

Identifiers

PMID39810252
PMCPMC11734402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.